Meanwhile, Zyprexa, the top seller for giant Eli Lilly, has seen its annual sales dropslowly in recent years as competitors such as Pfizer 's (nyse: PFE - news - people ) Geodon and Abilify, from Bristol-Myers Squibb (nyse: BMY - news - people ), have boasted that they cause less weight gain.